Drug
Ropivacaine Hydrochloride Injection
Ropivacaine Hydrochloride Injection is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_4
1
33%
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (66.7%)
Phase 41 (33.3%)
Trials by Status
terminated133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_2
Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA
NCT06509958
completedphase_4
Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery
NCT05345249
unknownphase_2
Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management
NCT05744674
Clinical Trials (3)
Showing 3 of 3 trials
NCT06509958Phase 2
Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA
NCT05345249Phase 4
Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery
NCT05744674Phase 2
Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3